Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Natus Medical has completed its acquisition of Sonamed, which manufactures and markets the clarity screener and associated disposable supplies that aid medical practitioners in screening for hearing loss in newborns.
Subscribe to our email newsletter
Natus acquired all outstanding shares of Sonamed capital stock for $9 million cash, exclusive of direct costs of the acquisition.
Jim Hawkins, president and CEO of Natus, said: We are very pleased to announce the completion of this acquisition. We expect the Clarity screener to further fill out our product line in newborn hearing screening. With two-thirds of Sonamed’s revenue coming from disposable supplies, combined with their high gross profit margin, we believe Sonamed’s products will be an ideal fit for our business model.